Open AccessVoriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial
Author(s) -
Mahmoud A. Ghannoum,
N. Isham,
Daniel J. Sheehan
Publication year - 2006
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00818-06
Subject(s) - dermatophyte , voriconazole , griseofulvin , fluconazole , tinea capitis , medicine , itraconazole , mycosis , dermatology , microbiology and biotechnology , antifungal , biology , surgery
In this study, the voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to fluconazole and griseofulvin. The MIC ranges of voriconazole, fluconazole, and griseofulvin, were 0.002 to 0.06 μg/ml, 0.25 to 32 μg/ml, and 0.125 to 2.0 μg/ml, respectively.